1. Home
  2. KW vs CLDX Comparison

KW vs CLDX Comparison

Compare KW & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • CLDX
  • Stock Information
  • Founded
  • KW 1977
  • CLDX N/A
  • Country
  • KW United States
  • CLDX United States
  • Employees
  • KW N/A
  • CLDX N/A
  • Industry
  • KW Real Estate
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KW Finance
  • CLDX Health Care
  • Exchange
  • KW Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • KW 1.4B
  • CLDX 1.3B
  • IPO Year
  • KW 1992
  • CLDX 2008
  • Fundamental
  • Price
  • KW $8.62
  • CLDX $17.38
  • Analyst Decision
  • KW Hold
  • CLDX Buy
  • Analyst Count
  • KW 1
  • CLDX 8
  • Target Price
  • KW $13.00
  • CLDX $54.29
  • AVG Volume (30 Days)
  • KW 765.0K
  • CLDX 776.1K
  • Earning Date
  • KW 05-07-2025
  • CLDX 05-05-2025
  • Dividend Yield
  • KW 5.58%
  • CLDX N/A
  • EPS Growth
  • KW N/A
  • CLDX N/A
  • EPS
  • KW N/A
  • CLDX N/A
  • Revenue
  • KW $511,600,000.00
  • CLDX $7,020,000.00
  • Revenue This Year
  • KW $32.54
  • CLDX N/A
  • Revenue Next Year
  • KW $45.44
  • CLDX $27.01
  • P/E Ratio
  • KW N/A
  • CLDX N/A
  • Revenue Growth
  • KW N/A
  • CLDX 1.99
  • 52 Week Low
  • KW $8.02
  • CLDX $16.46
  • 52 Week High
  • KW $11.88
  • CLDX $47.00
  • Technical
  • Relative Strength Index (RSI)
  • KW 42.04
  • CLDX 33.94
  • Support Level
  • KW $8.40
  • CLDX $19.48
  • Resistance Level
  • KW $9.07
  • CLDX $20.38
  • Average True Range (ATR)
  • KW 0.27
  • CLDX 1.00
  • MACD
  • KW -0.02
  • CLDX -0.21
  • Stochastic Oscillator
  • KW 35.00
  • CLDX 20.18

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: